Amanda Lochner Selected Research

Amanda Lochner Research Topics

Disease

18	Infarction (Infarctions) 12/2020 - 01/2005
11	Reperfusion Injury 08/2018 - 01/2005
9	Obesity 01/2018 - 05/2008
7	Insulin Resistance 03/2019 - 09/2012
7	Hypoxia (Hypoxemia) 09/2011 - 01/2002
6	Ischemia 06/2012 - 05/2002
4	Body Weight (Weight, Body) 10/2014 - 05/2008
3	Heart Diseases (Heart Disease) 01/2018 - 11/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021 - 02/2015
2	Weight Gain 03/2019 - 10/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2015 - 09/2012
2	Cardiomegaly (Heart Hypertrophy) 10/2014 - 05/2008
2	Myocardial Infarction 06/2012 - 11/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2011 - 04/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2020
1	HIV Infections (HIV Infection) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Body Weight Changes 10/2014
1	Hyperphagia (Overeating) 09/2012
1	Atherosclerosis 05/2012
1	Hypertrophy 09/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2011
1	Necrosis 02/2006

Drug/Important Bio-Agent (IBA)

8	MelatoninIBA 12/2020 - 01/2006
7	Insulin (Novolin)FDA Link 11/2017 - 05/2008
6	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 03/2011
5	Phosphotransferases (Kinase)IBA 08/2018 - 02/2011
4	Fatty Acids (Saturated Fatty Acids)IBA 03/2019 - 05/2008
4	Triglycerides (Triacylglycerol)IBA 10/2014 - 05/2008
4	p38 Mitogen-Activated Protein KinasesIBA 03/2011 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
3	Melatonin Receptors (Melatonin Receptor)IBA 08/2018 - 01/2006
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 10/2004 - 05/2002
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021 - 04/2005
2	Formoterol Fumarate (Oxis)FDA Link 06/2017 - 07/2014
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2014 - 11/2008
2	Nonesterified Fatty Acids (NEFA)IBA 06/2012 - 05/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012 - 01/2002
2	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 02/2006 - 03/2004
2	Cyclic NucleotidesIBA 01/2005 - 01/2002
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Glycogen Synthase (Synthase I)IBA 01/2019
1	NF-E2-Related Factor 2IBA 08/2018
1	SirtuinsIBA 08/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	sanguinarineIBA 06/2017
1	pyrazolanthroneIBA 06/2017
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2016
1	Ataxia Telangiectasia Mutated ProteinsIBA 02/2015
1	Blood Glucose (Blood Sugar)IBA 10/2014
1	CarbohydratesIBA 07/2014
1	Glycogen Synthase Kinase 3IBA 10/2013
1	phospholambanIBA 10/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2013
1	Mitochondrial Permeability Transition PoreIBA 01/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2013
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 09/2012
1	Sucrose (Saccharose)IBA 09/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2012
1	4-hydroxyphenylglycine (oxfenicine)IBA 06/2012
1	Endothelium-Dependent Relaxing Factors (Endothelium Derived Relaxing Factor)IBA 05/2012
1	Peptides (Polypeptides)IBA 09/2011
1	ProteomeIBA 09/2011
1	Glycogen Synthase KinasesIBA 09/2011
1	GlycogenIBA 09/2011
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 03/2011
1	Free Radical ScavengersIBA 03/2011
1	AntioxidantsIBA 03/2011
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2011
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2011
1	Oxygen (Dioxygen)IBA 09/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2009
1	WortmanninIBA 01/2009
1	Mitogen-Activated Protein KinasesIBA 04/2006
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2006
1	SB 203580IBA 02/2006
1	CME-Carbodiimide (CMEC)IBA 02/2006
1	SulfonamidesIBA 04/2005
1	isoquinolineIBA 04/2005
1	Adenosine Monophosphate (AMP)IBA 04/2005
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 04/2005
1	protein kinase modulatorIBA 04/2005
1	ColforsinIBA 04/2005
1	HMR 1098IBA 01/2005
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2005
1	Sildenafil Citrate (Viagra)FDA Link 01/2005
1	Phosphodiesterase 5 InhibitorsIBA 01/2005
1	1,1-diethyl-2-hydroxy-2-nitrosohydrazineIBA 10/2004
1	OxidesIBA 10/2004
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2002
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 05/2002

Therapy/Procedure

1	Ligation 10/2020
1	Art Therapy 01/2018
1	Therapeutics 11/2008